Loading...

James Lightwood, PhD

Title(s)Associate Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Phone415-514-0939
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Global Health
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lightwood J, Anderson S, Glantz SA. Predictive validation and forecasts of short-term changes in healthcare expenditure associated with changes in smoking behavior in the United States. PLoS One. 2020; 15(1):e0227493. PMID: 31945079.
      View in: PubMed
    2. Baum A, Aguilar-Gomez S, Lightwood J, Bruzelius E, Glantz SA, Basu S. Estimating the long-run relationship between state cigarette taxes and county life expectancy. Tob Control. 2020 Jan; 29(1):81-88. PMID: 30705247.
      View in: PubMed
    3. Yao T, Sung HY, Wang Y, Lightwood J, Max W. Healthcare Costs of Secondhand Smoke Exposure at Home for U.S. Children. Am J Prev Med. 2019 02; 56(2):281-287. PMID: 30553690.
      View in: PubMed
    4. Max WB, Sung HY, Lightwood J, Wang Y, Yao T. Modelling the impact of a new tobacco product: review of Philip Morris International's Population Health Impact Model as applied to the IQOS heated tobacco product. Tob Control. 2018 11; 27(Suppl 1):s82-s86. PMID: 30275170.
      View in: PubMed
    5. Wang Y, Sung HY, Lightwood J, Chaffee BW, Yao T, Max W. Health Care Utilization and Expenditures Attributable to Smokeless Tobacco Use Among US Adults. Nicotine Tob Res. 2018 09 25; 20(11):1359-1368. PMID: 29059335.
      View in: PubMed
    6. Sung HY, Wang Y, Yao T, Lightwood J, Max W. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014. Nicotine Tob Res. 2018 08 14; 20(suppl_1):S88-S98. PMID: 30125019.
      View in: PubMed
    7. Wang Y, Sung HY, Yao T, Lightwood J, Max W. Infrequent and Frequent Nondaily Smokers and Daily Smokers: Their Characteristics and Other Tobacco Use Patterns. Nicotine Tob Res. 2018 05 03; 20(6):741-748. PMID: 28186549.
      View in: PubMed
    8. Wang Y, Sung HY, Yao T, Lightwood J, Max W. Health Care Utilization and Expenditures Attributable to Cigar Smoking Among US Adults, 2000-2015. Public Health Rep. 2018 May/Jun; 133(3):329-337. PMID: 29688130.
      View in: PubMed
    9. Tingting Yao, Hai-Yen Sung, Yingning Wang, James Lightwood, Wendy Max. Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults. Tobacco Induced Diseases. 2018 Mar 1; 16(1).
      View in: Publisher Site
    10. Yao T, Sung HY, Wang Y, Lightwood J, Max W. Healthcare costs attributable to secondhand smoke exposure at home for U.S. adults. Prev Med. 2018 03; 108:41-46. PMID: 29288781.
      View in: PubMed
    11. Yao T, Max W, Sung HY, Glantz SA, Goldberg RL, Wang JB, Wang Y, Lightwood J, Cataldo J. Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S. PLoS One. 2017; 12(11):e0187399. PMID: 29112988.
      View in: PubMed
    12. L Wilson, EJ Yi, J Lightwood, B Lee, U Garay. PHP10 Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina. Value in Health. 2017 Oct 1; 20(9):a899.
      View in: Publisher Site
    13. Wang Y, Sung HY, Yao T, Lightwood J, Max W. Factors associated with short-term transitions of non-daily smokers: socio-demographic characteristics and other tobacco product use. Addiction. 2017 May; 112(5):864-872. PMID: 27886652.
      View in: PubMed
    14. Lightwood J, Glantz SA. Smoking Behavior and Healthcare Expenditure in the United States, 1992-2009: Panel Data Estimates. PLoS Med. 2016 05; 13(5):e1002020. PMID: 27163933.
      View in: PubMed
    15. Yao T, Sung HY, Wang Y, Lightwood J, Max W. Sociodemographic Differences Among U.S. Children and Adults Exposed to Secondhand Smoke at Home: National Health Interview Surveys 2000 and 2010. Public Health Rep. 2016 Mar-Apr; 131(2):357-66. PMID: 26957671.
      View in: PubMed
    16. Soller RW, Ho T, Lightwood JM. Improved Label and Liver Warning for Nonprescription Acetaminophen Products. Ther Innov Regul Sci. 2015 Nov; 49(6):890-897. PMID: 30222378.
      View in: PubMed
    17. Sung HY, Wang Y, Yao T, Lightwood J, Max W. Polytobacco Use of Cigarettes, Cigars, Chewing Tobacco, and Snuff Among US Adults. Nicotine Tob Res. 2016 May; 18(5):817-26. PMID: 26136525.
      View in: PubMed
    18. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. Health benefits of reducing sugar-sweetened beverage intake in high risk populations of California: results from the cardiovascular disease (CVD) policy model. PLoS One. 2013; 8(12):e81723. PMID: 24349119.
      View in: PubMed
    19. B. Lee, O.U. Garay, J. Goldhaber-Fiebert, J. Tang, J. Lightwood, L.S. Wilson. PHP5 Argentina’s Generic Drug Law: Was It Successful?. Value in Health. 2013 Nov 1; 16(7):a672.
      View in: Publisher Site
    20. Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients. J Manag Care Pharm. 2013 Sep; 19(7):534-41. PMID: 23964614.
      View in: PubMed
    21. Lightwood J, Glantz SA. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008. PLoS One. 2013; 8(2):e47145. PMID: 23418411.
      View in: PubMed
    22. R. William Soller, Christopher Shaheen, Jennifer Yen, John Rose, James Lightwood. Improvement of the Drug Allergy Alert for Nonprescription NSAIDs. Therapeutic Innovation & Regulatory Science. 2012 May 1; 46(3):336-343.
      View in: Publisher Site
    23. Max W, Sung HY, Lightwood J. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016. Tob Control. 2013 May; 22(e1):e10-5. PMID: 22253003.
      View in: PubMed
    24. Cheng KW, Glantz SA, Lightwood JM. Association between smokefree laws and voluntary smokefree-home rules. Am J Prev Med. 2011 Dec; 41(6):566-72. PMID: 22099232.
      View in: PubMed
    25. Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA. Evaluation of value-based insurance design with a large retail employer. Am J Manag Care. 2011 Oct; 17(10):682-90. PMID: 22106461.
      View in: PubMed
    26. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5. PMID: 21722862.
      View in: PubMed
    27. Lightwood J, Glantz S. Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med. 2011 Jan; 72(2):166-72. PMID: 21168248.
      View in: PubMed
    28. Kirsten Bibbins-Domingo, Glenn M. Chertow, Pamela G. Coxson, Andrew Moran, James M. Lightwood, Mark J. Pletcher, Lee Goldman. Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease. Obstetrical & Gynecological Survey. 2010 Jul 1; 65(7):441-442.
      View in: Publisher Site
    29. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9. PMID: 20089957.
      View in: PubMed
    30. Wang LM, Wong M, Lightwood JM, Cheng CM. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother. 2010 Jan; 44(1):28-34. PMID: 20040698.
      View in: PubMed
    31. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7. PMID: 19833999.
      View in: PubMed
    32. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009 Oct 06; 120(14):1373-9. PMID: 19770392.
      View in: PubMed
    33. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54. PMID: 19221376.
      View in: PubMed
    34. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20. PMID: 19095162.
      View in: PubMed
    35. Lightwood JM, Dinno A, Glantz SA. Effect of the California tobacco control program on personal health care expenditures. PLoS Med. 2008 Aug 26; 5(8):e178. PMID: 18752344.
      View in: PubMed
    36. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 06; 357(23):2371-9. PMID: 18057339.
      View in: PubMed
    37. Soller RW, Lightwood JM. Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling. J Am Pharm Assoc (2003). 2007 Jul-Aug; 47(4):484-90. PMID: 17616494.
      View in: PubMed
    38. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005 Oct-Dec; 32(4):381-92. PMID: 16215448.
      View in: PubMed
    39. Sharon M. Hall, James M. Lightwood, Gary L. Humfleet, Alan Bostrom, Victor I. Reus, Ricardo Mu??oz. Cost-Effectiveness of Bupropion, Nortriptyline, and Psychological Intervention in Smoking Cessation. The Journal of Behavioral Health Services & Research. 2005 Oct 1; 32(4):381???392.
      View in: Publisher Site
    40. Lightwood J. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug; 46(1):39-78. PMID: 12920700.
      View in: PubMed
    41. Lightwood J, Fleischmann KE, Glantz SA. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol. 2001 May; 37(6):1683-4. PMID: 11345384.
      View in: PubMed
    42. Wilson LS, Lightwood J. Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen. 2001; 8(4):187-96. PMID: 11743035.
      View in: PubMed
    43. B. Fox, J. Lightwood, S. A. Glantz. International implications of the United States ‘global settlement’ of tobacco litigation. Tobacco: The Growing Epidemic. 2000 Jan 1; 826-829.
      View in: Publisher Site
    44. Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999 Dec; 104(6):1312-20. PMID: 10585982.
      View in: PubMed
    45. Wilson LS, Lightwood JM. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol. 1999 Jul; 71(3):171-81. PMID: 10404134.
      View in: PubMed
    46. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997 Aug 19; 96(4):1089-96. PMID: 9286934.
      View in: PubMed
    47. Glantz SA, Fox BJ, Lightwood JM. Tobacco litigation. Issues for public health and public policy. JAMA. 1997 Mar 05; 277(9):751-3. PMID: 9042849.
      View in: PubMed